Guggenheim Maintains Buy on Waters, Raises Price Target to $490
10/1/2026
Impact: 85
Healthcare
Guggenheim analyst Subbu Nambi has maintained a Buy rating on Waters (NYSE: WAT) and increased the price target from $440 to $490. This adjustment reflects a positive outlook for the company's stock performance.
AI summary, not financial advice
Share: